ARCHIVES

Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

Bill Clinton Endorses NBCC’s 2020 Goal

January 14, 2011

In Brief: William Paul to Head AIDS Research Officer; Schachman Is NIH Extramural Obudsman

February 25, 1994

Neurosurgeons Say They Wouldn’t Step Into The MRI Van; Should An Asymptomatic Editor?

May 8, 2009

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

NCI Changes Deadlines For Two RFAS

July 18, 1997

Mammography Reports Complete; Breast Project to Continue

March 25, 1977